Oysco 500 with D Interactions
There are 275 drugs known to interact with Oysco 500 with D (calcium/vitamin d), along with 11 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 17 are major, 205 are moderate, and 53 are minor.
- View all 275 medications that may interact with Oysco 500 with D
- View Oysco 500 with D alcohol/food interactions (1)
- View Oysco 500 with D disease interactions (11)
Most frequently checked interactions
View interaction reports for Oysco 500 with D (calcium / vitamin d) and the medicines listed below.
- alendronate
- amlodipine
- aspirin
- carvedilol
- clonazepam
- docusate
- ferrous sulfate
- fluoxetine
- folic acid
- furosemide
- gabapentin
- hydroxyzine
- ibuprofen
- levothyroxine
- lisinopril
- loratadine
- losartan
- metformin
- metoprolol
- multivitamin
- omeprazole
- potassium chloride
- pravastatin
- prednisone
- simvastatin
- trazodone
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Oysco 500 with D alcohol/food interactions
There is 1 alcohol/food interaction with Oysco 500 with D (calcium / vitamin d).
Oysco 500 with D disease interactions
There are 11 disease interactions with Oysco 500 with D (calcium / vitamin d) which include:
- cardiovascular adverse effects
- phosphate calcifications
- cardiac contraction/conduction
- malabsorption
- renal dysfunction
- sarcoidosis
- arrhythmia
- electrolyte imbalance
- hypercalcemia
- renal dysfunction
- hepatobiliary dysfunction
Report options
QR code containing a link to this page
More about Oysco 500 with D (calcium / vitamin d)
- Oysco 500 with D consumer information
- Compare alternatives
- Side effects
- Dosage information
- Drug class: vitamin and mineral combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.